Anti-GD2-ch14.18/CHO coated nanoparticles mediate glioblastoma (GBM)-specific delivery of the aromatase inhibitor, Letrozole, reducing proliferation, migration and chemoresistance in patient-derived GBM tumor cells
Oncotarget | February 4, 2017 | Volume: 8 | Issue: 10 | Pages: 16605-16620
10.18632/oncotarget.15073
| PMID 28178667